KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Other Non-Current Assets (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Other Non-Current Assets for 15 consecutive years, with $63.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 102.35% to $63.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $63.8 million, a 102.35% increase, with the full-year FY2025 number at $63.8 million, up 102.35% from a year prior.
  • Other Non-Current Assets was $63.8 million for Q4 2025 at Supernus Pharmaceuticals, up from $1.4 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $63.8 million in Q4 2025 to a low of $1.4 million in Q3 2025.
  • A 5-year average of $38.0 million and a median of $39.3 million in 2022 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: skyrocketed 5523.98% in 2021, then fell 23.83% in 2025.
  • Supernus Pharmaceuticals' Other Non-Current Assets stood at $49.2 million in 2021, then dropped by 19.15% to $39.8 million in 2022, then decreased by 2.47% to $38.8 million in 2023, then dropped by 18.79% to $31.5 million in 2024, then soared by 102.35% to $63.8 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Other Non-Current Assets are $63.8 million (Q4 2025), $1.4 million (Q3 2025), and $28.0 million (Q2 2025).